It has a lot to claw back in terms of share price.
I think it will , steady and slow.
Next catalyst would be FDA CVM update. This could be a huge one.
In the mean time, we may a get a surprise approval for some states in US where Cannabis legislation is not that strict.
Just my thoughts. DYOR
Ann: June 2021 Quarterly Activities and Cashflow Reports, page-5
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)